Bispecific antibodies (BsAbs) are an advanced class of engineered antibodies designed to bind two different antigens or epitopes simultaneously. Unlike traditional monoclonal antibodies, which target a single antigen, BsAbs can engage two distinct targets, offering unique therapeutic opportunities in cancer treatment.
